Off-label drug use in palliative medicine: Delphi study for the consensus of evidence-based treatment recommendations.

ABSTRACT:

Background

Off-label use of drugs is an integral part of everyday clinical practice in palliative medicine. However, it is associated with many uncertainties, that is, drug therapy safety or legal issues including cost coverage. Healthcare professionals often lack time and resources for comprehensive literature search and patient-specific risk-benefit analyses.

Aim

The aim of this project is to develop, evaluate and rate agreement/disagreement on treatment recommendations for off-label use in adult palliative medicine.

Design

Online Delphi study with two rounds each to rate agreement/disagreement with treatment recommendations for off-label use in adult palliative medicine. An international expert panel consisting of physicians, pharmacists and nurses working in palli

SUBMITTER: Pugge S 

PROVIDER: S-EPMC12033383 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature